Placemark Investments’s Haemonetics HAE Stock Holding History

Placemark Investments’s Portfolio HAE Stock Details HAE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	$1.27M	Sell	34,092 -1,084	-3%	-$39.7K	0.02%	767
2014 Q3	$1.23M	Sell	35,176 -4,845	-12%	-$173K	0.02%	754
2014 Q2	$1.41M	Buy	40,021 +905	+2%	+$30.2K	0.03%	704
2014 Q1	$1.27M	Sell	39,116 -9,675	-20%	-$370K	0.02%	704
2013 Q4	$2.06M	Sell	48,791 -5,266	-10%	-$217K	0.03%	548
2013 Q3	$2.15M	Buy	54,057 +2,207	+4%	+$92.6K	0.04%	504
2013 Q2	$2.15M	Buy	+51,850	New	+$2.1M	0.05%	471

Other funds holding HAE

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

WHG

Westwood Holdings Group Dallas, Texas $13.7B AUM 21.48% 1-Year Est. Return

VNIM

Vaughan Nelson Investment Management Houston, Texas $11.3B AUM 53% 1-Year Est. Return

BCIM

Black Creek Investment Management Toronto, Ontario, Canada $1.86B AUM 15.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

VBA

Van Berkom & Associates Montreal, Quebec, Canada $3.08B AUM 12.07% 1-Year Est. Return

Placemark Investments's HAE Position: Q4 2014 in Review

Placemark Investments reduced its Haemonetics (HAE) stake by 3.1% in Q4 2014, selling an estimated $39.7K and leaving 34,092 shares worth $1.27M. The position accounts for 0.02% of the portfolio, ranked #767.

Placemark Investments first reported a position in HAE in Q2 2013 and has held it in 7 quarters since. The position peaked at $2.15M in Q3 2013. 173 funds tracked by Wall St. Rank hold HAE as of Q4 2014.

Placemark Investments held 34,092 shares of Haemonetics worth $1.27M as of Q4 2014.
Placemark Investments sold 1,084 Haemonetics shares in Q4 2014, an estimated $39.7K.
Haemonetics made up 0.02% of Placemark Investments's portfolio in Q4 2014, its #767 holding.
Placemark Investments first reported a position in Haemonetics in Q2 2013 and has held it in 7 quarters since.
Placemark Investments's Haemonetics position peaked at $2.15M in Q3 2013.
173 funds tracked by Wall St. Rank held Haemonetics as of Q4 2014.

Based on Placemark Investments's 13F filing for Q4 2014, filed 17 Feb 2015.